|
1
|
Blechacz B and Gores GJ:
Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and
treatment. Hepatology. 48:308–321. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Blechacz B: Cholangiocarcinoma: Current
knowledge and new developments. Gut Liver. 11:13–26. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fairweather M, Balachandran VP and
D'Angelica MI: Surgical management of biliary tract cancers. Chin
Clin Oncol. 5:632016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Razumilava N and Gores GJ:
Cholangiocarcinoma. Lancet. 383:2168–2179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cho MS, Kim SH, Park SW, Lim JH, Choi GH,
Park JS, Chung JB and Kim KS: Surgical outcomes and predicting
factors of curative resection in patients with hilar
cholangiocarcinoma: 10-year single-institution experience. J
Gastrointest Surg. 16:1672–1679. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jarnagin WR, Fong Y, DeMatteo RP, Gonen M,
Burke EC, Bodniewicz BS J, Youssef BA M, Klimstra D and Blumgart
LH: Staging, resectability, and outcome in 225 patients with hilar
cholangiocarcinoma. Ann Surg. 234:507–517; discussion 517–509.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Romero-Cordoba SL, Salido-Guadarrama I,
Rodriguez-Dorantes M and Hidalgo-Miranda A: miRNA biogenesis:
Biological impact in the development of cancer. Cancer Biol Ther.
15:1444–1455. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tufekci KU, Oner MG, Meuwissen RL and Genc
S: The role of microRNAs in human diseases. Methods Mol Biol 1107.
33–50. 2014. View Article : Google Scholar
|
|
9
|
Singh RP, Massachi I, Manickavel S, Singh
S, Rao NP, Hasan S, Mc Curdy DK, Sharma S, Wong D, Hahn BH and
Rehimi H: The role of miRNA in inflammation and autoimmunity.
Autoimmun Rev. 12:1160–1165. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen L, Song J, Cui J, Hou J, Zheng X, Li
C and Liu L: microRNAs regulate adipocyte differentiation. Cell
Biol Int. 37:533–546. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Di Leva G, Garofalo M and Croce CM:
MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao L, Fan W, Fan Y and Gao S:
MicroRNA-214 promotes the proliferation, migration and invasion of
gastric cancer MKN28 cells by suppressing the expression of Dact2.
Exp Ther Med. 16:4909–4917. 2018.PubMed/NCBI
|
|
13
|
Xiang J, Hang JB, Che JM and Li HC: MiR-25
is up-regulated in non-small cell lung cancer and promotes cell
proliferation and motility by targeting FBXW7. Int J Clin Exp
Pathol. 8:9147–9153. 2015.PubMed/NCBI
|
|
14
|
Zhou J, Wang W, Li W, Wu L, Li G, Shi J
and Zhou S: The polymorphism in miR-25 attenuated the oncogenic
function in gastric cancer. Tumour Biol. 37:5515–5520. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang J, Gong X, Tian K, Chen D, Sun J,
Wang G and Guo M: miR-25 promotes glioma cell proliferation by
targeting CDKN1C. Biomed Pharmacother. 71:7–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang C, Wang X, Su Z, Fei H, Liu X and Pan
Q: MiR-25 promotes hepatocellular carcinoma cell growth, migration
and invasion by inhibiting RhoGDI1. Oncotarget. 6:36231–36244.
2015.PubMed/NCBI
|
|
17
|
Wang H, Li C, Jian Z, Ou Y and Ou J:
TGF-beta1 reduces mir-29a expression to promote tumorigenicity and
metastasis of cholangiocarcinoma by targeting HDAC4. PloS One.
10:e01367032015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dumortier M, Ladam F, Damour I, Vacher S,
Bieche I, Marchand N, de Launoit Y, Tulasne D and Chotteau-Lelievre
A: ETV4 transcription factor and MMP13 metalloprotease are
interplaying actors of breast tumorigenesis. Breast Cancer Res.
20:732018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gomez-Macias GS, Garza-Rodriguez ML,
Garza-Guajardo R, Monsivais-Ovalle D, Ancer-Rodriguez J,
Barrera-Saldana HA and Barboza-Quintana O: Overexpression of the
matrix metalloproteinase 11 gene is a potential biomarker for type
1 endometrial cancer. Oncol Lett. 16:1073–1078. 2018.PubMed/NCBI
|
|
21
|
Sotgiu ML: Effects of alpha
2-adrenoceptors blockade on the inhibition of the nociceptive
jaw-opening reflex by the lateral reticular nucleus in rabbits.
Arch Ital Biol. 127:63–67. 1989.PubMed/NCBI
|
|
22
|
Phanthaphol N, Techasen A, Loilome W,
Thongchot S, Thanan R, Sungkhamanon S, Khuntikeo N, Yongvanit P and
Namwat N: Upregulation of TCTP is associated with
cholangiocarcinoma progression and metastasis. Oncol Lett.
14:5973–5979. 2017.PubMed/NCBI
|
|
23
|
Song P, Du Y, Song W, Chen H, Xuan Z, Zhao
L, Chen J, Guo D, Jin C, Zhao Y, et al: KCa3.1 as an effective
target for inhibition of growth and progression of intrahepatic
cholangiocarcinoma. J Cancer. 8:1568–1578. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Daya M, Loilome W, Techasen A, Thanee M,
Sa-Ngiamwibool P, Titapun A, Yongvanit P and Namwat N: Progranulin
modulates cholangiocarcinoma cell proliferation, apoptosis, and
motility via the PI3K/pAkt pathway. Onco Targets Ther. 11:395–408.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Khuu C, Utheim TP and Sehic A: The three
paralogous MicroRNA clusters in development and disease, miR-17-92,
miR-106a-363, and miR-106b-25. Scientifica (Cairo) 2016.
13796432016.
|
|
26
|
Brett JO, Renault VM, Rafalski VA, Webb AE
and Brunet A: The microRNA cluster miR-106b~25 regulates adult
neural stem/progenitor cell proliferation and neuronal
differentiation. Aging (Albany NY). 3:108–124. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zwaka TP and Thomson JA: Differentiation
of human embryonic stem cells occurs through symmetric cell
division. Stem Cells. 23:146–149. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ehrlich L, Hall C, Venter J, Dostal D,
Bernuzzi F, Invernizzi P, Meng F, Trzeciakowski JP, Zhou T,
Standeford H, et al: miR-24 Inhibition increases menin expression
and decreases cholangiocarcinoma proliferation. Am J Pathol.
187:570–580. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu C, Zhang J, Cao X, Yang Q and Xia D:
Effect of Mir-122 on human cholangiocarcinoma proliferation,
invasion, and apoptosis through P53 expression. Med Sci Monit.
22:2685–2690. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Razumilava N, Bronk SF, Smoot RL, Fingas
CD, Werneburg NW, Roberts LR and Mott JL: miR-25 targets
TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and
promotes apoptosis resistance in cholangiocarcinoma. Hepatology.
55:465–475. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li BS, Zuo QF, Zhao YL, Xiao B, Zhuang Y,
Mao XH, Wu C, Yang SM, Zeng H, Zou QM and Guo G: MicroRNA-25
promotes gastric cancer migration, invasion and proliferation by
directly targeting transducer of ERBB2, 1 and correlates with poor
survival. Oncogene. 34:2556–2565. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang M, Yang YO, Jin Q, Shang L and Zhang
J: Function of miR-25 in the invasion and metastasis of esophageal
squamous carcinoma cells and bioinformatical analysis of the
miR-106b-25 cluster. Exp Ther Med. 15:440–446. 2018.PubMed/NCBI
|
|
33
|
Ding X, Zhong T, Jiang L, Huang J, Xia Y
and Hu R: miR-25 enhances cell migration and invasion in
non-small-cell lung cancer cells via ERK signaling pathway by
inhibiting KLF4. Mol Med Rep. 17:7005–7016. 2018.PubMed/NCBI
|
|
34
|
Sanchez-Mejias A, Kwon J, Chew XH, Siemens
A, Sohn HS, Jing G, Zhang B, Yang H and Tay Y: A novel
SOCS5/miR-18/miR-25 axis promotes tumorigenesis in liver cancer.
Int J Cancer. 144:311–321. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Long J, Jiang C, Liu B, Dai Q, Hua R, Chen
C, Zhang B and Li H: Maintenance of stemness by miR-589-5p in
hepatocellular carcinoma cells promotes chemoresistance via STAT3
signaling. Cancer Lett. 423:113–126. 2018. View Article : Google Scholar : PubMed/NCBI
|
